Skip to main content
SpringerLink
Log in

The Role of Endogenous Interferon-α in HIV Infection and Autoimmune Diseases—An Overview

  • Conference paper
Interferons

Abstract

In the course of HIV infection, the role of interferon-α (IFN-α) seems to be rather paradoxical: “It is possible to view alpha-IFN as either a therapeutical agent or as a major contributor to the pathology associated with AIDS.” (S. Krown, 1992).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Krown SE, Niedzwiecki D, Bhalla RB, Flomenberg N, Bundow D, Chapman D (1991) Relationship and prognostic value of endogenous alpha-IFN, b2-microglobuline, and neopterin serum levels in patients with Kaposi’s Sarcoma and AIDS. J Acquir Immune Defic Syndr, 4: 871–880

    PubMed  CAS  Google Scholar 

  2. Mildvan D, Machado SG, Wilets I, Grossberg SE (1992) Endogenous IFN and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 339: 453–456

    Article  PubMed  CAS  Google Scholar 

  3. Hess G, Rossol S, Rossol, R, Meyer zum Buschenfelde KH (1991) TNF and IFN as prognostic markers in HIV-infection. Infection 19 [Suppl 2]: 93–97

    Article  Google Scholar 

  4. Francis ML, Meltzer MS, Gendelman HE (1992) IFN’s in the persistence, pathogenesis, and treatment of HIV-infection. AIDS Res Hum Retroviruses 8: 199–207

    Article  PubMed  CAS  Google Scholar 

  5. Voth RS, Rossol S, Klein K et al (1990) Differential gene expression of alpha-IFN and TNF-alpha in PBMCs from patients with AIDS-related complex and AIDS. J Immunol 144: 970–975

    PubMed  CAS  Google Scholar 

  6. Howell DM, Feldman M, Siegal FP, Pettera L, Fitzgerald-Bocarsly P (1993) Peripheral blood of AIDS patients contains cells capable of providing accessory function of the natural killer cell-mediated lysis of herpes simplex virus-infected targets despite low alpha-IFN production. J Acquir Immune Defic Syndr 6: 15–23

    PubMed  CAS  Google Scholar 

  7. Lallemand CP, Rizza P, Lebon P (1991) Mechanisms of the inhibition of the IFN response in HIV-infected cells. Congr Biotech AIDS 94, p 157 (abstract)

    Google Scholar 

  8. Levy DE (1993) Induction of alpha-IFN stimulated gene expression. Forum-Trends in Experimental and Clinical Medicine 3: 641–650

    Google Scholar 

  9. Gutch MJ, Reich N (1991) Repression of the interferon signal transduction pathway by adenovirus particles EiA oncogene. Proc Natl Acad Sci USA 88: 7914–7917

    Article  Google Scholar 

  10. Foster GR (1991) Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to alpha- and gamma-interferons and double-stranded RNA.Proc Natl Acad Sci USA 88: 2888–2892

    Article  PubMed  CAS  Google Scholar 

  11. Ferbas JJ, Toso JF, Logar AJ, Navratil JS, Rinaldo CR (1994) CD4(+) blood dendritic cells are potent producers of alpha-IFN in response to in vitro HIV-i infection. J Immunol 152: 4649–4662

    PubMed  CAS  Google Scholar 

  12. Feldman SB, Milone MC, Kloser P, Fitzgerald-Bocarsly P (1995) Functional deficiences in two distinct alpha-IFN producing cell populations in PBMCs from HIV-seropositive patients. J Leuk Biol 57: 214–220

    CAS  Google Scholar 

  13. Tyring SK, Cauda R, Tumbarellov M et al (1991) Synthetic peptides corresponding to sequences in HIV-envelope gp4i and gpi20 enhance in vitro production of IL-i and TNF, but depress production of alpha-IFN, gamma-IFN and IL-2. Viral Immunol 4: 33–42

    Article  PubMed  CAS  Google Scholar 

  14. Nair MPN, Kailash CC, Stadler I, Sweet A, Schwartz SA (1995) Differential effects of HI V-i envelope protein gp 120 on IFN production by mononuclear cells from adults and neonates. Clin Diagn Lab Immunol 22: 432–438

    Google Scholar 

  15. Grunfeld C, Kotler DP, Shigenaga JK et al (1991) Circulating alpha-IFN levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 90: 154–162

    PubMed  CAS  Google Scholar 

  16. Von Sydow M, Sonnerborg A, Gaines H, Strannegard O (1991) Alpha-IFN and TNF-alpha in serum of patients in various stages of HIV-i infection. AIDS Res Hum Retroviruses 7: 375–380

    Article  Google Scholar 

  17. Rossol S, Voth R, Laubenstein HP et al (1989) IFN-production in patients infected with HIV-i. J Infect Dis 159: 815–821

    Article  PubMed  CAS  Google Scholar 

  18. Lau AS, Livesey JF (1989) Endotoxin induction of TNF is enhanced by acid-labile alpha-IFN in AIDS. J Clin Invest 84: 738–743

    Article  PubMed  CAS  Google Scholar 

  19. Poli G, Biswas P, Fauci AS (1994) IFN’s in the pathogenesis and treatment of HIV-infection. Antiviral Research 24: 221–233

    Article  PubMed  CAS  Google Scholar 

  20. Edlin BR, St. Clair MH, Pitha PM et al (1992) In-vitro resistance to zidovudine and alpha-IFN in HIV-i isolates from patients: correlations with treatment duration and response. Ann Intern Med 117: 457–460

    PubMed  CAS  Google Scholar 

  21. Capobianchi MR, Ankel H, Ameglio F, Paganelli R, Pizzoli PM, Dianzani F (1992) Recombinant glycoprotein 120 of HIV is a potent IFN inducer. AIDS Res Hum Retroviruses 8: 575–579

    Article  PubMed  CAS  Google Scholar 

  22. Francis ML, Meitzer MS (1993) Induction of alpha-IFN by HIV-i in monocyte-enriched PBM requires gp 120-CD4 interaction but not virus replication. J Immunol 151: 2208–2216

    PubMed  CAS  Google Scholar 

  23. Buimovici-Klein E, McKinley GF, Lange M et al (1992) Modulation of alpha-IFN levels by AZT treatment in HIV-seropositive patients. J Exp Pathol 6: 31–39

    PubMed  CAS  Google Scholar 

  24. Torres G (1993) Use of alpha-IFN’s in HIV-disease. In: Jäger H (ed) AIDS: Eine Krankheit wird behandelbar. Ecomed Verlagsgesellschaft, Landsberg, p 189–193

    Google Scholar 

  25. Schröder HC, Müller WEG, Pfleiderer W (1992) With oligoadenylates and intracellular immunity against retroviruses. Nachr Chem Tech Lab 40: 1352–1360

    Article  Google Scholar 

  26. Cohen B, Gothelf Y, Vaiman D, Chen L, Revel M, Chebath J (1991) IL-6 induces the 2–5 oligoadenylate synthetase gene in Mi cells through an effect on the IFN-responsive enhancer. Cytokine 3: 83–91

    Article  PubMed  CAS  Google Scholar 

  27. Von Wussow P, Jakschies D, Hochkeppel HK, Fibich C, Penner L, Deicher H (1990) The human intracellular Mx-homologous protein is specifically induced by type 1 IFN’s. Eur J Immunol 20: 2015–2019

    Article  Google Scholar 

  28. Jakschies D, Zachaval R, Müller R et al (1994) Strong transient expression of the type 1 IFN-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology 19: 857–865

    PubMed  CAS  Google Scholar 

  29. Pitha PM, Popik W, Su Y (1995) Targeted expression of the transduced IFN-α gene: application for gene therapy, 1st International Symp on HIV & Cytokines, (abstract) p 53

    Google Scholar 

  30. Lallemand C, Tovey MG (1995) Differential expression of constitutive type 1 IFN in U937 cells infected or not by HIV. 1st International Symp on HIV 8c Cytokines, (abstract) p 76

    Google Scholar 

  31. Leissner P, Calenda V, Marigliano M (1995) Gene therapy for HIV-i infection: inhibition of viral replication by HIV-i inducible IFN-alpha-, beta- and gamma-genes, 1st International Symp on HIV 8c Cytokines, (abstract) 15, p 51

    Google Scholar 

  32. Yee AM, Buyon JP, Yip YK (1989) Alpha-IFN associated with SLE is not intrinsically acid-labile. J Exp Med 169: 987–993

    Article  PubMed  CAS  Google Scholar 

  33. Krieg AM, Steinberg AD (1990) Retroviruses and autoimmunity. J Autoimmun 3: 137–166

    Article  PubMed  CAS  Google Scholar 

  34. Ranki A, Kurki P, Riepponen S, Stephansson E (1992) Antibodies to retroviral proteins in autoimmune connective tissue disease. Relation to clinical manifestations and ribonucleoprotein autoantibodies. Arthritis Rheum 35: 1483–1491

    Article  PubMed  CAS  Google Scholar 

  35. Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D, Sturfelt G (1994) Increased antiretroviral antibody reactivity in sera from a defined population of patients with SLE. Correlation with autoantibodies and clinical manifestations. Arthritis Rheum 37: 57–66

    Article  PubMed  CAS  Google Scholar 

  36. Toivanen P, Toivanen A, Brines R (1994) When is autoimmune disease not an autoimmune disease? Immunol Today 15: 556–559

    Article  PubMed  CAS  Google Scholar 

  37. Clerici M, Shearer GM (1994) The Thi-Th2-hypothesis of HIV-infection: new insights. Immunol Today 15: 575–581

    Article  PubMed  CAS  Google Scholar 

  38. Ho DD, Mougdil MS, Alam M (1989) Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. New Engl J Med 321: 1621–1625

    Article  PubMed  CAS  Google Scholar 

  39. Kelso A (1995) Thi and Th2 subsets: paradigms lost? Immunol Today 16: 374–379

    Article  PubMed  CAS  Google Scholar 

  40. Inaba K, Schuler G, Steinman RM (1993) GM-CSF-α granulocyte/macrophage/dendritic cell stimulation factor. In: Van Furth R (ed) Hematopoetic growth factors and mononuclear phagocytes. Karger, Basel, pp 187–196

    Google Scholar 

  41. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9: 271–296

    Article  CAS  Google Scholar 

  42. Grabbe S, Beissert S, Schwarz T, Granstein RD (1995) Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunity? Immunol Today 16: 117–121

    Article  PubMed  CAS  Google Scholar 

  43. Lamont A (1994) Are we closer to selective immunotherapy for autoimmune diseases? Immunol Today 15: 45–47

    Article  PubMed  CAS  Google Scholar 

  44. Hohlfeld R, Londei M, Massacesi L, Salvetti M (1995) T-cell autoimmunity in multiple sclerosis. Immunol Today 16: 259–261

    Article  PubMed  CAS  Google Scholar 

  45. Report of the Quality Standards Subcommittee of the American Academy of Neurology (1994). Neurology, 44: 1537–1540

    Google Scholar 

  46. Segel LA, Jäger E, Elias D, Cohen IR (1995) A quantitative model of autoimmune disease and T-cell vaccination: does more mean less? Immunol Today 16: 80–84

    Article  PubMed  CAS  Google Scholar 

  47. Theofilopoulos AN (1995) The basis of autoimmunity. Part 1: mechanisms of aberrant self-recognition. Immunol Today 16: 90–98

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Tossing
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Heinrich-Heine-Universität Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Carlo Aul  & Wolfgang Schneider  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Tossing, G. (1997). The Role of Endogenous Interferon-α in HIV Infection and Autoimmune Diseases—An Overview. In: Aul, C., Schneider, W. (eds) Interferons. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60411-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60411-9_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-61051-9

  • Online ISBN: 978-3-642-60411-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation